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OBJECTIVEdEmerging in vitro and animal evidence suggests that methylmercury could
increase type 2 diabetes, but little evidence exists in humans. We aimed to prospectively de-
termine associations of mercury exposure, as assessed by biomarker measurement, with incident
diabetes.
RESEARCH DESIGN AND METHODSdWe used neutron activation analysis to mea-
sure toenail mercury, an objective biomarker of methylmercury exposure, in 9,267 adults free of
diabetes at baseline in two separate U.S. prospective cohorts. Incident diabetes was identiﬁed
from biennial questionnaires and conﬁrmed by validated supplementary questionnaire using
symptoms, diagnostic tests, and medical therapy. Associations of mercury exposure with in-
cident diabetes were assessed using Cox proportional hazards.
RESULTSdDuring mean 6 SD follow-up of 19.7 6 7.0 years, 1,010 new cases of diabetes
were diagnosed. The 95th percentile of toenail mercury was 1.32 mg/g in men and 0.76 mg/g in
women, corresponding to exposures ;3.5-fold and 2-fold higher than the U.S. Environmental
Protection Agency reference dose. In multivariable analyses, toenail mercury concentrations
were not associatedwith higher incidence of diabetes in women, men, or both cohorts combined.
Comparing the highest to lowest quintile of exposure, the hazard ratio (95% CI) for incident
diabetes was 0.86 (0.66–1.11) in women, 0.69 (0.42–1.15) in men, and 0.77 (0.61–0.98) in the
combined cohorts. Findings were similar when more extreme categories (deciles) of mercury
were compared, and in analyses stratiﬁed by ﬁsh or omega-3 consumption, BMI, and age.
CONCLUSIONSdThese ﬁndings from two separate large prospective cohorts do not sup-
port adverse effects of methylmercury on development of diabetes in men or women at usual
levels of exposure seen in these populations.
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Emerging evidence from in vitromod-els and animal experiments suggeststhat methylmercury could increase
risk of type 2 diabetes. In these experi-
ments, methylmercury causes dysfunc-
tion of pancreatic b-cells by increasing
production of reactive oxygen species,
increasing phosphatidylinositol 3-kinase
activity and Akt phosphorylation, de-
creasing insulin secretion, and activating
apoptosis (1,2). Given the large and grow-
ing health and economic burdens of di-
abetes (3), conﬁrming and quantifying
the potential effects of methylmercury
on diabetes risk would be of tremendous
public health consequence. For example,
this would be crucial to inform potential
extension of current recommendations
on balancing beneﬁts versus risks of ﬁsh
consumption versus methylmercury ex-
posure, which are focused on women of
childbearing age and young children to
optimize neurodevelopment in early life
(4), to the general population to modify
the risk of developing diabetes.
Very little evidence on methylmer-
cury exposure and diabetes risk is avail-
able in humans, including mixed results
from one ecological study (5), one small
retrospective study (6), and one cross-
sectional analysis (7). Findings on ﬁsh
consumption, the major source of meth-
ylmercury, and diabetes risk have also
been mixed, with some studies observing
decreased risk, others increased risk, and
others no signiﬁcant association (8). In-
terestingly, the Coronary Artery Risk De-
velopment in Young Adults (CARDIA)
cohort recently reported a positive asso-
ciation between chronic methylmercury
exposure and diabetes (9). To our knowl-
edge, no other studies have prospectively
evaluated whether mercury exposure is
associated with incident diabetes. To de-
termine whether chronic methylmercury
exposure might increase the risk of diabe-
tes, we prospectively investigated the re-
lationship between toenail mercury
levels, an objective biomarker of methyl-
mercury exposure, and incidence of dia-
betes among 9,267 men and women in
two separate U.S. cohort studies.
RESEARCH DESIGN AND
METHODS
Population and design
The designs of the Health Professionals
Follow-up Study (HPFS) and Nurses’
Health Study (NHS) have been described
(10,11). The HPFS enrolled 51,529 U.S.
men, all health professionals, who were
40–75 years of age in 1986; and the
NHS enrolled 121,700 U.S. women, all
registered nurses, who were 30–55 years
of age in 1976. In both cohorts, partici-
pants have been followed with biennial
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questionnaires on medical history, risk
factors, lifestyle, and disease incidence.
For the present analysis, we used pro-
spectively collected data on toenail mer-
cury concentrations from prior nested
case-control studies of incident cardio-
vascular disease in both cohorts (12,13)
(see Supplementary Data online for de-
tails). The study was designed by the au-
thors and approved by the human
subjects committees of all author institu-
tions. All participants provided implied
consent by return of completed question-
naires and toenail samples. Funding for
the present investigation was provided
by the National Institute of Environmen-
tal Health Sciences, National Institutes of
Health.
From among NHS and HPFS partic-
ipants who had stored toenail samples
and were free of cardiovascular disease at
the time of toenail sampling (1982–1983
inNHS; 1987 inHPFS), wemeasured toe-
nail mercury concentrations in 9,308men
and women, including 4,654 participants
who went on to develop coronary heart
disease (CHD) or stroke during follow-up
and 4,654 participants who did not de-
velop CHD or stroke during equivalent
follow-up (matched on month of toenail
sample return, age, sex, race, and smok-
ing status). We excluded dentists from
these measurements, as their toenail mer-
cury also reﬂects occupational exposure
to inorganic (rather thanmethyl) mercury
(14). For the present analysis, we ex-
cluded 41 participants with prevalent di-
abetes at the time of toenail sampling,
leaving a total of 9,267 individuals with
measured toenail mercury concentrations
who were free of prevalent diabetes at
baseline.
Toenail mercury concentrations
Toenail concentrations of mercury and
selenium, which in some animal models
mitigate toxicity of mercury (15), were
measured using neutron activation analy-
sis by personnel unaware of the partici-
pants’ clinical information (12). This
biomarker provides a measure of chronic
methylmercury exposure over approxi-
mately the prior year. See Supplementary
Data for details on analytic methods, valid-
ity, and reproducibility of these measures.
Ascertainment of incident diabetes
Potential cases of incident diabetes were
identiﬁed from biennial questionnaires
asking about any new physician-
diagnosed diabetes. These potential cases
were then reviewed and conﬁrmed using
a validated supplementary questionnaire
that obtained data on symptoms, diagnos-
tic tests, and medical therapy. Incident
diabetes was diagnosed according to orig-
inal National Diabetes Data Group criteria,
based on the presence of one or more of
the following: 1) classic symptoms plus a
plasma glucose concentration$140 mg/dL
(7.8 mmol/L) in the fasting state or a ran-
domly measured plasma glucose concen-
tration$200 mg/dL (11.1 mmol/L); 2) in
the absence of symptoms, at least two
elevated plasma glucose concentrations
on different occasions ($140 mg/dL fast-
ing, $200 mg/dL randomly measured,
or$200 mg/dL 2-h postoral glucose chal-
lenge); or 3) drug treatment with hypogly-
cemic medication (insulin or an oral
hypoglycemic agent). These diagnostic
criteria were modiﬁed after 1998 to ac-
count for the new lower diagnostic cutoff
for fasting glucose concentration of
126 mg/dL. The validity of these supple-
mentary questionnaire criteria for diag-
nosing diabetes in these cohorts has been
demonstrated. In subsets of participants in
whom diabetes was diagnosed based on
these criteria and then compared with a
full review of medical records, 98% in
NHS and 97% in HPFS had a conﬁrmed
diagnosis of diabetes (16,17).
Covariates
Data on demographics, risk factors, and
lifestyle habits were collected via vali-
dated self-administered questionnaires,
using the closest report preceding toenail
sample collection from each participant
(18). Information on weight and height
was obtained; self-reported weight was
validated against technician-measured
weight (r = 0.96) (19). Physical activity
was assessed as metabolic equivalent
tasks (METs) using validated question-
naires (20). Usual dietary habits were as-
sessed using validated semiquantitative
food frequency questionnaires that in-
quired about usual consumption of foods,
beverages, and supplements over the
prior year (21,22). Fish and seafood
omega-3 consumption were quantiﬁed
as previously described (23).
Statistical analysis
Associations of toenail mercury concen-
trations with incident diabetes were eval-
uated using Cox proportional hazards,
with time at risk from the time of toenail
sampling until the ﬁrst event, death, or
censoring at the date of return of the last
questionnaire in 2008. The proportional
hazards assumption was tested and not
rejected based on Schoenfeld residuals.
Mercury concentrationswere evaluated as
indicator categories in quintiles and also
in deciles to evaluate a broader range of
dose response. Because toenail mercury
measures were measured as part of a prior
nested case-control study of incident
cardiovascular disease, participants were
weighted according to their inverse prob-
ability of being sampled from the overall
cohorts (SAS PROCPHREG,NORMALIZE
option). Individuals selected as future car-
diovascular case subjects were given a
weight of 1, and control subjects received
a weight of 17 in the NHS (women) and 24
in the HPFS (men). With such weighting,
results can be interpreted as generalizable
to the full cohorts.
Tests for trend were performed by
assigning participants themedian value in
their quintile of exposure and evaluating
this as a continuous variable. Statistical
evaluation for interaction was performed
by multiplying this variable by the effect
modiﬁer of interest and evaluating the
Wald test for the multiplicative interac-
tion term. Potential confounding was
assessed using multivariable models ad-
justed for demographics, major diabetes
risk factors, and lifestyle and dietary
habits including ﬁsh and omega-3 fatty
acid consumption. Multivariable model-
ing was guided by parsimony, clinical
relevance of covariates, observed strength
of association between covariates and
exposure or outcome, and percent change
in risk estimate when covariates were
included. Missing covariates (,1%)
were imputed using multiple imputation
(24).We performed sensitivity analyses to
minimize potential reverse causation due
to the presence of potential unrecognized
diabetes at baseline by excluding cases
occurring during the ﬁrst 2 years of follow-
up, and to minimize potential misclassiﬁ-
cation due to exposure changes over time
by restricting analyses to events within 10
years of toenail sampling. We also per-
formed sensitivity analyses restricting to
symptomatic cases who reported at least
one classic symptom at the time of diag-
nosis. All analyses were performed using
SAS version 9.1 (SAS Institute) with two-
tailed a = 0.05.
RESULTSdAt baseline, mean 6 SD
age was 61.2 6 8.9 years among men
and 53.7 6 6.1 years among women
(Table 1). The 95th percentile of toenail
mercury concentration was 1.32 mg/g in
men and 0.76 mg/g in women, corre-
sponding to concentrations in hair
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of ;3.67 and 2.11 mg/g (12), respec-
tively, or ;3.5- and 2-fold higher than
the U.S. Environmental Protection
Agency (EPA) reference dose exposure
corresponding to 1.0 mg/g in hair (25).
Unadjusted (bivariate) associations of
baseline characteristics of participants in
these cohorts according to toenail mer-
cury concentrations have been previously
reported (12,13). In brief, higher mercury
concentrations were associated with more
frequent hypercholesterolemia, slightly
lower BMI, modestly higher physical ac-
tivity, and greater alcohol use. Mercury
concentrations were also positively asso-
ciated with ﬁsh consumption (Spearman
r = 0.39) and dietary factors related to ﬁsh
consumption, including slightly lower in-
takes of saturated fat, monounsaturated
fat, trans fat, and dietary cholesterol and
slightly higher intakes of protein and
polyunsaturated fat. Mercury concentra-
tions were not signiﬁcantly associated
with age, smoking, family history of dia-
betes, or presence of hypertension.
During 19.7 6 7.0 years of follow-
up, 1,010 new cases of diabetes were
diagnosed. The median duration of follow-
up from time of toenail sampling to diagno-
sis of diabetes was 12.7 years (interquartile
range 7.5–18.1). In both age- and sex-
adjusted as well as multivariable-adjusted
analyses, toenail mercury concentrations
were not associated with higher inci-
dence of diabetes in women, men, or
overall (Table 2). Comparing the highest
to the lowest quintile of mercury expo-
sure, the fully adjusted hazard ratio (HR)
(95% CI) for incident diabetes was 0.86
(0.66–1.11) (P trend = 0.21) in women,
0.69 (0.42–1.15) (P trend = 0.12) in men,
and 0.77 (0.61–0.98) (P trend = 0.04) in
both cohorts combined.
Findings were not altered with fur-
ther adjustment for total energy intake or
toenail selenium concentrations or if we
adjusted for estimated dietary long-chain
omega-3 fatty acids rather than ﬁsh con-
sumption (data not shown). Higher risk
of diabetes with higher mercury exposure
was also not seen in analyses stratiﬁed by
ﬁsh consumption, BMI, or age (Table 3).
Indeed, trends toward lower incidence of
diabetes with higher mercury exposure
were seen when ﬁsh consumption was
low among overweight or obese subjects
and among older subjects.
Findings were also similar across a
broader dose response of deciles of toenail
mercury (Supplementary Table 1), and in
sensitivity analyses excluding early cases
of diabetes (within the ﬁrst 2 years) or late
cases (after the ﬁrst 10 years) (Supple-
mentary Table 2). Results were also simi-
lar or even more strongly inverse when
restricted to symptomatic cases (48.7%
of all cases) reporting at least one classic
symptom at the time of diagnosis (Sup-
plementary Table 3).
In prior analyses in these cohorts,
self-reported ﬁsh and dietary long-chain
omega-3 consumption were associated
with a modestly higher incidence of di-
abetes (26). For example, compared with
participants consuming ﬁsh less than
once amonth, the pooledmultivariate rel-
ative risk (95% CI) among those consum-
ing ﬁsh ﬁve or more times per week was
1.22 (1.08–1.39). Similarly, across quin-
tiles of long-chain omega-3 fatty acids, the
pooled multivariate relative risk (95% CI)
was 1.24 (1.09–1.40). When we reevalu-
ated these associations in the present sub-
set of cohort participants who also had
mercury measures, the ﬁndings were
very similar: both self-reported ﬁsh and
omega-3 consumption were associated
with a higher incidence of diabetes (data
not shown). In exploratory analyses, we
evaluated joint associations with incident
diabetes of toenail mercury concentra-
tions and self-reported ﬁsh consumption
(Supplementary Table 4) or estimated
long-chain omega-3 consumption (Sup-
plementary Table 5). Compared with
the reference group of individuals having
both low toenail mercury and low ﬁsh (or
low omega-3) consumption, no clear pat-
tern of risk was evident. Indeed, partici-
pants having both higher toenail mercury
Table 1dBaseline characteristics of 9,267 U.S. men and women in two separate
prospective cohorts*
Characteristic
Men
(n = 2,541)
Women
(n = 6,726)
Age (years) 61.4 6 9.0 53.8 6 6.1
U.S. region (%)
West 22 15
Midwest 32 18
South 27 12
Other 19 55
Smoking status (%)
Never 43 36
Former 47 27
Current 10 37
Family history of myocardial infarction (%) 35 21
Family history of diabetes (%) 21 22
Hypertension (%) 22 8
Hypercholesterolemia (%) 12 4
BMI (kg/m2) 25.6 6 3.0 24.5 6 4.6
Physical activity (METs/week) 19.2 6 25.9 13.8 6 18.8
Alcohol (drinks/day) 0.9 6 1.2 0.5 6 0.9
Toenail selenium (mg/g) 0.92 6 0.60 0.79 6 0.27
Toenail mercury, median (5th–95th%) (mg/g) 0.30 (0.07–1.33) 0.21 (0.07–0.76)
Fish (servings/week) 2.0 6 1.8 1.8 6 1.6
Processed meat (servings/day) 0.4 6 0.6 0.3 6 0.4
Unprocessed red meat (servings/day) 0.7 6 0.5 0.6 6 0.5
Vegetables (servings/day) 3.2 6 2.5 3.3 6 1.8
Fruits (servings/day) 1.7 6 1.5 2.2 6 1.4
Whole grains (g/day) 20.7 6 17.9 16.0 6 14.2
Dietary EPA and DHA (mg/day) 266 6 224 184 6 152
Total energy (kcal/day) 2,057 6 642 1,731 6 531
Saturated fat (% energy) 11.3 6 2.8 12.6 6 3.0
Monounsaturated fat (% energy) 12.5 6 2.7 12.8 6 2.9
Polyunsaturated fat (% energy) 5.8 6 1.5 6.4 6 1.8
Trans fat (% energy) 1.3 6 0.5 1.9 6 0.6
Protein (% energy) 18.3 6 3.3 17.9 6 3.4
Values aremean6 SD (continuous characteristics) or% (categorical characteristics) except for toenail mercury,
which is reported asmedian (5th–95th%). *Weighted according to the inverse probability of sampling of each
individual from the overall cohorts. DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid.
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and lower ﬁsh or omega-3 consumption
tended to have lowest incidence of diabe-
tes, whereas participants having both
higher toenail mercury and higher ﬁsh or
omega-3 consumption did not have a sig-
niﬁcantly different incidence of diabetes.
CONCLUSIONSdIn two separate
large U.S. prospective cohort studies, we
found no evidence that methylmercury
exposure was associated with higher risk
of diabetes. These ﬁndings were robust
in a variety of different subgroups and
sensitivity analyses. These results provide
evidence that at usual levels of exposure
seen in these men and women, methyl-
mercury exposure is unlikely to increase
the risk of diabetes.
When the cohorts were combined
and in some population subgroups,
higher mercury levels were associated
with trends toward lower incidence of
diabetes. Because methylmercury does
not induce biological effects that would
plausibly protect against diabetes, this
observed relationship is likely due to
confounding; i.e., links between higher
methylmercury exposure and other fac-
tors that lower risk of diabetes. Consistent
with the major source of exposure, higher
toenail mercury was associated with fac-
tors linked to higher ﬁsh consumption,
including slightly lower BMI, modestly
higher physical activity, and greater alco-
hol use. Although we adjusted for these
factors and self-reported ﬁsh consump-
tion in multivariable models, residual
confounding due to imperfect measure-
ments or other unmeasured factors can-
not be excluded. These two cohorts also
comprised relatively racially and socio-
economically uniform populations,
greatly minimizing confounding by race,
education, and income.
Interestingly, overall ﬁsh consump-
tion in these cohorts has been linked to a
modestly higher incidence of diabetes
(26), whereas toenail mercury concentra-
tions were associated with trends toward
lower risk. These differences may partly
relate to choices of ﬁsh species consumed;
associations for overall ﬁsh consumption
reﬂect the average intakes of all types of
ﬁsh consumed, whereas associations for
toenail mercury reﬂect intakes of a limited
set of large, predatory ﬁsh species. The
varying associations could also partly re-
late to differences in validity or bias of self-
reportedﬁsh consumption, comparedwith
toenail mercury as an objective biomarker.
Table 2dMultivariable-adjusted risk of incident diabetes according to mercury exposure among 9,267 U.S. men and women in
two separate prospective cohorts*
Quintile of toenail mercury concentration†
Q1 Q2 Q3 Q4 Q5 P for trend
Women (n = 6,726)
Mercury median (mg/g) 0.09 0.15 0.21 0.31 0.56
Geometric mean (mg/g) 0.08 0.15 0.21 0.31 0.64
Cases of incident diabetes
(total = 788) 175 175 146 141 151
HR (95% CI)
Age and sex adjusted 1.00 (reference) 0.90 (0.70–1.15) 0.82 (0.64–1.06) 0.74 (0.57–0.95) 0.93 (0.74–1.19) 0.75
Multivariable‡ 1.00 (reference) 0.88 (0.68–1.13) 0.80 (0.61–1.03) 0.68 (0.52–0.90) 0.88 (0.68–1.14) 0.57
Multivariable + dietx 1.00 (reference) 0.85 (0.66–1.10) 0.78 (0.60–1.02) 0.67 (0.51–0.88) 0.86 (0.66–1.11) 0.48
Men (n = 2,541)
Mercury median (mg/g) 0.10 0.19 0.30 0.48 0.91
Geometric mean (mg/g) 0.09 0.19 0.30 0.48 1.04
Cases of incident diabetes
(total = 222) 57 40 39 46 40
HR (95% CI)
Age and sex adjusted 1.00 (reference) 0.93 (0.62–1.39) 0.65 (0.43–1.01) 0.65 (0.42–1.01) 0.79 (0.52–1.19) 0.28
Multivariable‡ 1.00 (reference) 0.96 (0.64–1.46) 0.69 (0.44–1.09) 0.59 (0.37–0.94) 0.71 (0.44–1.13) 0.15
Multivariable + dietx 1.00 (reference) 1.00 (0.64–1.55) 0.74 (0.46–1.19) 0.55 (0.34–0.90) 0.69 (0.42–1.15) 0.12
All participants combined
(n = 9,267)
Mercury median (mg/g) 0.09 0.16 0.23 0.34 0.66
Geometric mean (mg/g) 0.08 0.16 0.23 0.35 0.76
Cases of incident diabetes
(total = 1,010) 233 224 186 181 186
HR (95% CI)
Age and sex adjusted 1.00 (reference) 1.06 (0.86–1.30) 0.79 (0.63–0.98) 0.78 (0.63–0.98) 0.89 (0.72–1.10) 0.17
Multivariable‡ 1.00 (reference) 1.05 (0.85–1.29) 0.77 (0.61–0.97) 0.76 (0.60–0.96) 0.81 (0.64–1.02) 0.05
Multivariable + dietx 1.00 (reference) 0.98 (0.79–1.22) 0.75 (0.59–0.94) 0.75 (0.59–0.95) 0.77 (0.61–0.98) 0.04
*Analyseswereweightedaccording to the inverseprobability of each individual being sampled fromtheoverall cohorts.†Based on sex-speciﬁc quintile cut points whenwomen
and men were evaluated separately, and overall quintile cut points when men and women were combined. ‡Adjusted for age (years), sex, race (white or nonwhite),
region (West, Midwest, South, or other), month of toenail return, family history of diabetes (yes or no), smoking status (never, former, or current), BMI (kg/m2,
quintiles), hypertension (yes or no), hypercholesterolemia (yes or no), future cardiovascular disease case-control status (case or control), physical activity (METs/
week, quintiles), alcohol use (drinks/week, quintiles), and ﬁsh consumption (ﬁve categories). xFurther adjusted for consumption of whole grains (g/day, quintiles),
unprocessed meats (servings/day, quintiles), processed meats (servings/day, quintiles), fruits (servings/day, quintiles), and vegetables (servings/day, quintiles).
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When we evaluated joint associations
of ﬁsh or omega-3 consumption and
mercury levels, we did not ﬁnd any clear
pattern of joint associations that would
suggest offsetting beneﬁts versus risks.
Overall, the results provide little evi-
dence that higher methylmercury expo-
sure from ﬁsh consumption increases
risk of diabetes.
The CARDIA cohort recently reported
on the association between toenail mer-
cury concentrations and incident diabetes
(9). After adjustment for age, sex, race,
BMI, education, smoking, alcohol use,
physical activity, and family history, mer-
cury exposure was not signiﬁcantly associ-
ated with incident diabetes. However, after
further adjustment for dietary omega-3
intake, dietary magnesium, and toenail
selenium, a positive association was seen
(P trend = 0.02). These ﬁndings suggested
that, only after accounting for other bene-
ﬁcial components in ﬁsh, the remaining
methylmercury exposure might increase
risk of diabetes. Interestingly, this positive
association also appeared potentially
weaker among participants consuming
higher amounts of dietary omega-3 fatty
acids or magnesium. The reasons for
the divergent results between our ﬁndings
and those in CARDIA are unclear. Both
studies were prospective, included U.S.
adults, assessed toenail mercury concen-
trations using the same U.S. biomarker
laboratory, adjusted for major confound-
ers including other beneﬁcial components
in ﬁsh, and included participants with
similar overall absolute risk (in CARDIA,
7.2% of subjects developed diabetes dur-
ing 18 years of follow-up; in our cohorts,
10.9% developed diabetes during ;25
years of follow-up) and similar ranges of
mercury exposure. Among both our co-
horts combined, geometric mean mercury
exposure in the top quintile was twofold
higher than the U.S. EPA reference dose
(25), and in the top decile, nearly threefold
higher. These ranges of mercury exposure
were also similar to exposure levels docu-
mented in European populations (27,28)
and in nationally representative U.S.
surveys (29). Pooling our results with
those reported by CARDIA, no signiﬁ-
cant association was evident (Fig. 1).
CARDIA included fewer total partici-
pants (3,875 vs. 9,267) and fewer cases
of incident diabetes (280 vs. 1,010). In
comparison with our participants who
were largely middle age at baseline, the
CARDIA cohort was younger (20–32 years
of age at baseline), raising the possibility
that biological effects of methylmercuryT
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could inﬂuence diabetes risk in youth
but not middle age. Conversely, we did
not ﬁnd statistically signiﬁcant effect
modiﬁcation by age (P interaction =
0.71) or evidence for higher risk at
age ,50 years even with a similar num-
ber of cases in this age stratum as in the
entire CARDIA cohort. Differences in the
results between these studies could also be
due to chance.
We found inverse associations be-
tween mercury exposure and incident di-
abetes among people with low omega-3
intake or who were overweight or obese.
Whether the results in these groups
represent beneﬁts of ﬁsh consumption,
for which toenail mercury concentration
is a marker, or chance ﬁndings requires
further study. Given absence of a priori
hypotheses about interaction in these
subgroups, these ﬁndings require con-
ﬁrmation and should be interpreted
cautiously.
For sensitive subpopulations, spe-
ciﬁc guidance exists to balance beneﬁts
and risks of ﬁsh consumption versus
methylmercury exposure to optimize
brain development during gestation
and infancy (4,30). No corresponding
guidelines exist for the general adult
population, owing to insufﬁcient evi-
dence for any signiﬁcant long-term
effects of chronic low-level methylmer-
cury exposure in adults. Some early
studies suggested that methylmercury
exposure may be linked to higher CHD
(27,28), but our recent work in these two
large prospective cohort studies demon-
strated no evidence for increased risk of
either CHD or stroke at typical popula-
tion ranges of chronic methylmercury
exposure (12).
The Institute of Medicine, the U.S.
Dietary Guidelines, and the World
Health Organization have each con-
cluded that regular ﬁsh consumption
is a recommended part of a healthy diet
and that among adults, health beneﬁts
far outweigh potential risks (31–33).
Our ﬁndings provide further credence
to these conclusions, providing little ev-
idence that methylmercury exposure
from ﬁsh consumption increases diabe-
tes risk.
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